Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Endo Pharmaceuticals stock up on strong earnings, guidance
Bizjournals.com
Tuesday, March 1, 2011 - 9:12am
tags:
Endo, guidance, earnings
Pharma's Newest Acquisition Targets
Motley Fool
Tuesday, March 1, 2011 - 9:10am
tags:
M&A, Pfizer, GSK, AstraZeneca, Biogen Idec
Daiichi Sankyo nabs tiny Plexxikon in $935M deal
Fierce Biotech
Tuesday, March 1, 2011 - 7:57am
tags:
Plexxikon, Daiichi Sankyo, M&A
Glaxo Seeks $1.5 Billion in AIDS Drug Trial Against Abbott
Bloomberg
Tuesday, March 1, 2011 - 7:55am
tags:
GSK, Abbott Laboratories, AIDS
6 Health-Care IPOs; 3 Worth Watching
Motley Fool
Tuesday, March 1, 2011 - 7:54am
tags:
IPOs, Endocyte, AcelRx, Tornier, Pacira, Epocrates, MedQuist
Pfizer Updates Website With 17 New Drugs in Final Tests
Bloomberg
Tuesday, March 1, 2011 - 7:52am
tags:
Pfizer, pipelines
Mylan gets FDA approval for generic version of Pfizer's seizure and shingles drug Neurontin
Yahoo/AP
Tuesday, March 1, 2011 - 7:51am
tags:
Mylan, generics, FDA, Pfizer, Neurontin
Supreme Court Won’t Review Sales Rep Overtime
Pharmalot
Monday, February 28, 2011 - 2:29pm
tags:
drug reps, overtime lawsuits
Drugmakers Will Expand Which Sales Teams?
Pharmalot
Monday, February 28, 2011 - 1:58pm
tags:
drug reps
Merck Sees Delay in Closing Animal-Health Venture With Sanofi
WSJ Online
Monday, February 28, 2011 - 1:40pm
tags:
Merck, M&A, animal health, Sanofi
China Biotech Week in Review: Pharmaron Raises $40 Million in Venture Capital
Seeking Alpha
Monday, February 28, 2011 - 1:39pm
tags:
China, Pharmaron, Zhejiang Jolly Pharmaceutical, Shanghai Pharmaceutical, Sanofi
Shire wins FDA approval for ADHD drug
Bizjournals.com
Monday, February 28, 2011 - 1:37pm
tags:
FDA, Shire, ADHD, Intuniv
Drug Industry Rebuffed by Top U.S. Court on Sales Force Wages
Bloomberg
Monday, February 28, 2011 - 1:20pm
tags:
overtime lawsuits, drug reps, Merck, Novartis, Supreme Court
Is Eli Lilly a Stock for the Long Term?
Motley Fool
Monday, February 28, 2011 - 1:18pm
tags:
Eli Lilly
Regeneron Announces Strong Results In Gout Study
Forbes
Monday, February 28, 2011 - 12:26pm
tags:
gout, Regeneron, Arcalyst
Is Spectrum Pharmaceuticals the Perfect Stock?
Motley Fool
Monday, February 28, 2011 - 12:25pm
tags:
Spectrum Pharmaceuticals
PDL BioPharma settles legal dispute with Novartis
Yahoo/AP
Monday, February 28, 2011 - 12:23pm
tags:
PDL Biopharma, Novartis, Lucentis
Bayer Posts Fourth-Quarter Loss on Schering Brand Writedown
Bloomberg
Monday, February 28, 2011 - 12:22pm
tags:
Bayer, earnings
Delays to Generic Acne Medication Lifts Medicis 24%
Barron's
Monday, February 28, 2011 - 12:18pm
tags:
generics, Medicis, acne, Teva Pharmaceuticals, Sodolyn
FDA rejects filing on Santarus angioedema drug
Yahoo/AP
Monday, February 28, 2011 - 12:17pm
tags:
angioedema, FDA, Santarus, RHUCIN

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.